Discover 754 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 754
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Toledo OH, Ann Arbor MI, Detroit MI, Farmington MI,
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
for
Ischemic Stroke
Location: Toledo OH, Pittsburgh PA, Iowa City IA
Sponsor: Raul Nogueira
Sex: All
Age: 18+
Code: NCT05983757
Recruiting
Rapid Evacuation and Access of Cerebral Hemorrhage Trial
for
Stroke Hemorrhagic
Location: Toledo OH, Indianapolis IN, Evanston IL, Lexington KY,
Sponsor: Emory University
Sex: All
Age: 18 - 70
Code: NCT06870812
Recruiting
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
for
Pulmonary Embolism
Location: Toledo OH, Detroit MI, Columbus OH, Kettering OH,
Sponsor: Penumbra Inc.
Sex: All
Age: 18+
Code: NCT04798261
Recruiting
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
for
Ischemic Stroke, Acute Disease
Location: Toledo OH
Sponsor: ProMedica Health System
Sex: All
Age: 18 - 70+
Code: NCT06949228
Phase2, Phase3, Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Toledo OH, Ann Arbor MI, Detroit MI, Cleveland OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase3, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Toledo OH, Battle Creek MI, Akron OH, Kalamazoo MI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT07466316
Phase3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)